TRIVARX LTD - Announcements

Market Cap $9.816M Add to my watchlist

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology... TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

TRI	Proposed issue of securities - TRI		02/05/24	16.07KB	Share
TRI	Proposed issue of securities - TRI		02/05/24	19.84KB	Share
TRI	TrivarX Receives Firm Commitments to Raise $2.5 million	PRICE SENSITIVE	02/05/24	146.08KB	Share
TRI	Trading Halt	PRICE SENSITIVE	30/04/24	255.74KB	Share
TRI	March 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/04/24	384.67KB	Share
TRI	Cleansing Notice		26/03/24	92.35KB	Share
TRI	Application for quotation of securities - TRI		26/03/24	15.71KB	Share
TRI	Cleansing Notice		01/03/24	92.19KB	Share
TRI	Application for quotation of securities - TRI		01/03/24	15.73KB	Share
TRI	Appendix 4D & Half-Year Financial Report to 31 December 2023	PRICE SENSITIVE	28/02/24	773.88KB	Share
TRI	Positive Engagement Meeting with US FDA for MEB-001		28/02/24	168.2KB	Share
TRI	Response to ASX Price Query	PRICE SENSITIVE	22/02/24	340.86KB	Share
TRI	Cleansing Notice		15/02/24	103.1KB	Share
TRI	Application for quotation of securities - TRI		15/02/24	15.77KB	Share
TRI	Research Collaboration with Northern Michigan University		09/02/24	145.67KB	Share
TRI	TrivarX Receives $888k R&D Tax Incentive	PRICE SENSITIVE	08/02/24	102.8KB	Share
TRI	TRI-001 Algorithm and Phase 2 Trial Update	PRICE SENSITIVE	05/02/24	160.46KB	Share
TRI	December 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/24	275.48KB	Share
TRI	Notification of cessation of securities - TRI		21/12/23	21.54KB	Share
TRI	Cleansing Notice		19/12/23	103.87KB	Share
TRI	Application for quotation of securities - TRI		19/12/23	24.66KB	Share
TRI	Proposed issue of securities - TRI		18/12/23	24.37KB	Share
TRI	Change of Share Registry Details		12/12/23	93.26KB	Share
TRI	Results of Annual General Meeting		29/11/23	196.35KB	Share
TRI	Cleansing Notice		20/11/23	92.83KB	Share
TRI	Application for quotation of securities - TRI		20/11/23	24.6KB	Share
TRI	Phase 2 SAMDE Study Update	PRICE SENSITIVE	20/11/23	153.22KB	Share
TRI	Proposed issue of securities - TRI		16/11/23	24.37KB	Share
TRI	Investor Presentation - November 2023		16/11/23	1.02MB	Share
TRI	Cleansing Notice		15/11/23	104.01KB	Share
TRI	Application for quotation of securities - TRI		15/11/23	24.9KB	Share
TRI	Option Terms and Conditions		14/11/23	219.28KB	Share
TRI	Proposed issue of securities - TRI		14/11/23	25.87KB	Share
TRI	Proposed issue of securities - TRI		14/11/23	24.46KB	Share
TRI	Letter to Shareholders & Notice of AGM & Proxy Form		30/10/23	947.54KB	Share
TRI	September 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/23	256.22KB	Share
TRI	Completion of Consolidation of Capital		27/10/23	105.13KB	Share
TRI	Consolidation/Split - TRI		18/10/23	28.58KB	Share
TRI	Change in substantial holding		17/10/23	173.96KB	Share
TRI	Change of Director's Interest Notice - David Trimboli		16/10/23	280.6KB	Share
TRI	Change of Director's Interest Notice - Chris Ntoumenopoulos		16/10/23	278.22KB	Share
TRI	Notification regarding unquoted securities - MEB		13/10/23	23.59KB	Share
TRI	Notification regarding unquoted securities - MEB		13/10/23	23.65KB	Share
TRI	Cleansing Notice		13/10/23	167.46KB	Share
TRI	Application for quotation of securities - MEB		13/10/23	24.88KB	Share
TRI	Application for quotation of securities - MEB		13/10/23	24.87KB	Share
TRI	Change of company name and ASX code		11/10/23	131KB	Share
TRI	Notification of cessation of securities - MEB		09/10/23	21.57KB	Share
TRI	Results of General Meeting		06/10/23	130.89KB	Share
TRI	Board and Management Transition	PRICE SENSITIVE	06/10/23	159.19KB	Share
TRI	Notice of AGM and Closing Date for Director Nominations		06/10/23	125.97KB	Share
TRI	Appendix 4G		29/09/23	279.99KB	Share
TRI	Corporate Governance Statement		29/09/23	326.47KB	Share
TRI	2023 Annual Report		29/09/23	1.19MB	Share
TRI	Proposed issue of securities - MEB		06/09/23	29.39KB	Share
TRI	Letter to Shareholders & Notice of GM & Proxy Form	PRICE SENSITIVE	06/09/23	821.04KB	Share
TRI	Phase 2 Trial Commences for SAMDE Study	PRICE SENSITIVE	04/09/23	206.53KB	Share
TRI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	31/08/23	343.63KB	Share
TRI	Notification of cessation of securities - MEB		21/08/23	21.59KB	Share
TRI	Change in substantial holding		18/08/23	672.97KB	Share
TRI	Cleansing Notice		16/08/23	140.79KB	Share
TRI	Application for quotation of securities - MEB		16/08/23	25.06KB	Share
TRI	Proposed issue of securities - MEB	PRICE SENSITIVE	07/08/23	34.7KB	Share
TRI	Medibio Receives Firm Commitments to Raise $2.25m	PRICE SENSITIVE	07/08/23	190.07KB	Share
TRI	Trading Halt	PRICE SENSITIVE	03/08/23	272.13KB	Share
TRI	June 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/23	415.98KB	Share
TRI	Phase 1 Trial Completed for SAMDE Study	PRICE SENSITIVE	24/07/23	207.02KB	Share
TRI	Update on Breakthrough Device Designation with US FDA		21/07/23	154.26KB	Share
TRI	Notification regarding unquoted securities - MEB		05/07/23	26.5KB	Share
TRI	Notification regarding unquoted securities - MEB		05/07/23	26.33KB	Share
TRI	Notification regarding unquoted securities - MEB		05/07/23	26.09KB	Share
TRI	Application for quotation of securities - MEB		05/07/23	25.18KB	Share
TRI	Change of Director's Interest Notice - David Trimboli		22/06/23	277.26KB	Share
TRI	Change of Director's Interest Notice - Chris Ntoumenopoulos		22/06/23	277.33KB	Share
TRI	Notification regarding unquoted securities - MEB		22/06/23	25.95KB	Share
TRI	Application for quotation of securities - MEB		22/06/23	25.03KB	Share
TRI	Notification of cessation of securities - MEB		19/06/23	23.53KB	Share
TRI	Notification regarding unquoted securities - MEB		30/05/23	28.2KB	Share
TRI	Application for quotation of securities - MEB		29/05/23	25.11KB	Share
TRI	Medibio Completes Share Purchase Plan	PRICE SENSITIVE	29/05/23	149.36KB	Share
TRI	Results of Extraordinary General Meeting		23/05/23	150.56KB	Share
TRI	Investor Presentation - May 2023		18/05/23	721.66KB	Share
TRI	Change in Venue and Time for Extraordinary General Meeting		01/05/23	108.42KB	Share
TRI	March 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/04/23	399.18KB	Share
TRI	Letter to Shareholders & Notice of EGM & Proxy Form		21/04/23	634.19KB	Share
TRI	MEB Executes Bridging Loans with Directors	PRICE SENSITIVE	21/04/23	143.06KB	Share
TRI	Initial Director's Interest Notice - Thomas Young		17/04/23	150.24KB	Share
TRI	Share Purchase Plan Supplementary Prospectus	PRICE SENSITIVE	14/04/23	1.6MB	Share
TRI	Final Director's Interest Notice		12/04/23	235.53KB	Share
TRI	Board & Managment Changes & Change of Offices		12/04/23	230KB	Share
TRI	Update on Share Purchase Plan Timetable		06/04/23	238.93KB	Share
TRI	Appendix 3Z		16/03/23	226.53KB	Share
TRI	Resignation of Non-Executive Director		16/03/23	182.05KB	Share
TRI	Share Purchase Plan Prospectus	PRICE SENSITIVE	02/03/23	575.38KB	Share
TRI	Medibio Lodges Breakthrough Device Designation with FDA		27/02/23	238.29KB	Share
TRI	Update to Share Purchase Plan Timetable		24/02/23	221.92KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/23	701.09KB	Share
TRI	Change in substantial holding		23/02/23	176.43KB	Share
TRI	708A Cleansing Notice		23/02/23	173.49KB	Share
TRI	Application for quotation of securities - MEB		21/02/23	24.85KB	Share

TRI Proposed issue of securities - TRI
02/05/24		16.07KB	Share
TRI Proposed issue of securities - TRI
02/05/24		19.84KB	Share
TRI TrivarX Receives Firm Commitments to Raise $2.5 million
02/05/24	PRICE SENSITIVE	146.08KB	Share
TRI Trading Halt
30/04/24	PRICE SENSITIVE	255.74KB	Share
TRI March 2024 Quarterly Activities Report and Appendix 4C
29/04/24	PRICE SENSITIVE	384.67KB	Share
TRI Cleansing Notice
26/03/24		92.35KB	Share
TRI Application for quotation of securities - TRI
26/03/24		15.71KB	Share
TRI Cleansing Notice
01/03/24		92.19KB	Share
TRI Application for quotation of securities - TRI
01/03/24		15.73KB	Share
TRI Appendix 4D & Half-Year Financial Report to 31 December 2023
28/02/24	PRICE SENSITIVE	773.88KB	Share
TRI Positive Engagement Meeting with US FDA for MEB-001
28/02/24		168.2KB	Share
TRI Response to ASX Price Query
22/02/24	PRICE SENSITIVE	340.86KB	Share
TRI Cleansing Notice
15/02/24		103.1KB	Share
TRI Application for quotation of securities - TRI
15/02/24		15.77KB	Share
TRI Research Collaboration with Northern Michigan University
09/02/24		145.67KB	Share
TRI TrivarX Receives $888k R&D Tax Incentive
08/02/24	PRICE SENSITIVE	102.8KB	Share
TRI TRI-001 Algorithm and Phase 2 Trial Update
05/02/24	PRICE SENSITIVE	160.46KB	Share
TRI December 2023 Quarterly Activities Report and Appendix 4C
31/01/24	PRICE SENSITIVE	275.48KB	Share
TRI Notification of cessation of securities - TRI
21/12/23		21.54KB	Share
TRI Cleansing Notice
19/12/23		103.87KB	Share
TRI Application for quotation of securities - TRI
19/12/23		24.66KB	Share
TRI Proposed issue of securities - TRI
18/12/23		24.37KB	Share
TRI Change of Share Registry Details
12/12/23		93.26KB	Share
TRI Results of Annual General Meeting
29/11/23		196.35KB	Share
TRI Cleansing Notice
20/11/23		92.83KB	Share
TRI Application for quotation of securities - TRI
20/11/23		24.6KB	Share
TRI Phase 2 SAMDE Study Update
20/11/23	PRICE SENSITIVE	153.22KB	Share
TRI Proposed issue of securities - TRI
16/11/23		24.37KB	Share
TRI Investor Presentation - November 2023
16/11/23		1.02MB	Share
TRI Cleansing Notice
15/11/23		104.01KB	Share
TRI Application for quotation of securities - TRI
15/11/23		24.9KB	Share
TRI Option Terms and Conditions
14/11/23		219.28KB	Share
TRI Proposed issue of securities - TRI
14/11/23		25.87KB	Share
TRI Proposed issue of securities - TRI
14/11/23		24.46KB	Share
TRI Letter to Shareholders & Notice of AGM & Proxy Form
30/10/23		947.54KB	Share
TRI September 2023 Quarterly Activities Report and Appendix 4C
30/10/23	PRICE SENSITIVE	256.22KB	Share
TRI Completion of Consolidation of Capital
27/10/23		105.13KB	Share
TRI Consolidation/Split - TRI
18/10/23		28.58KB	Share
TRI Change in substantial holding
17/10/23		173.96KB	Share
TRI Change of Director's Interest Notice - David Trimboli
16/10/23		280.6KB	Share
TRI Change of Director's Interest Notice - Chris Ntoumenopoulos
16/10/23		278.22KB	Share
TRI Notification regarding unquoted securities - MEB
13/10/23		23.59KB	Share
TRI Notification regarding unquoted securities - MEB
13/10/23		23.65KB	Share
TRI Cleansing Notice
13/10/23		167.46KB	Share
TRI Application for quotation of securities - MEB
13/10/23		24.88KB	Share
TRI Application for quotation of securities - MEB
13/10/23		24.87KB	Share
TRI Change of company name and ASX code
11/10/23		131KB	Share
TRI Notification of cessation of securities - MEB
09/10/23		21.57KB	Share
TRI Results of General Meeting
06/10/23		130.89KB	Share
TRI Board and Management Transition
06/10/23	PRICE SENSITIVE	159.19KB	Share
TRI Notice of AGM and Closing Date for Director Nominations
06/10/23		125.97KB	Share
TRI Appendix 4G
29/09/23		279.99KB	Share
TRI Corporate Governance Statement
29/09/23		326.47KB	Share
TRI 2023 Annual Report
29/09/23		1.19MB	Share
TRI Proposed issue of securities - MEB
06/09/23		29.39KB	Share
TRI Letter to Shareholders & Notice of GM & Proxy Form
06/09/23	PRICE SENSITIVE	821.04KB	Share
TRI Phase 2 Trial Commences for SAMDE Study
04/09/23	PRICE SENSITIVE	206.53KB	Share
TRI Appendix 4E - Preliminary Final Report
31/08/23	PRICE SENSITIVE	343.63KB	Share
TRI Notification of cessation of securities - MEB
21/08/23		21.59KB	Share
TRI Change in substantial holding
18/08/23		672.97KB	Share
TRI Cleansing Notice
16/08/23		140.79KB	Share
TRI Application for quotation of securities - MEB
16/08/23		25.06KB	Share
TRI Proposed issue of securities - MEB
07/08/23	PRICE SENSITIVE	34.7KB	Share
TRI Medibio Receives Firm Commitments to Raise $2.25m
07/08/23	PRICE SENSITIVE	190.07KB	Share
TRI Trading Halt
03/08/23	PRICE SENSITIVE	272.13KB	Share
TRI June 2023 Quarterly Activities Report and Appendix 4C
31/07/23	PRICE SENSITIVE	415.98KB	Share
TRI Phase 1 Trial Completed for SAMDE Study
24/07/23	PRICE SENSITIVE	207.02KB	Share
TRI Update on Breakthrough Device Designation with US FDA
21/07/23		154.26KB	Share
TRI Notification regarding unquoted securities - MEB
05/07/23		26.5KB	Share
TRI Notification regarding unquoted securities - MEB
05/07/23		26.33KB	Share
TRI Notification regarding unquoted securities - MEB
05/07/23		26.09KB	Share
TRI Application for quotation of securities - MEB
05/07/23		25.18KB	Share
TRI Change of Director's Interest Notice - David Trimboli
22/06/23		277.26KB	Share
TRI Change of Director's Interest Notice - Chris Ntoumenopoulos
22/06/23		277.33KB	Share
TRI Notification regarding unquoted securities - MEB
22/06/23		25.95KB	Share
TRI Application for quotation of securities - MEB
22/06/23		25.03KB	Share
TRI Notification of cessation of securities - MEB
19/06/23		23.53KB	Share
TRI Notification regarding unquoted securities - MEB
30/05/23		28.2KB	Share
TRI Application for quotation of securities - MEB
29/05/23		25.11KB	Share
TRI Medibio Completes Share Purchase Plan
29/05/23	PRICE SENSITIVE	149.36KB	Share
TRI Results of Extraordinary General Meeting
23/05/23		150.56KB	Share
TRI Investor Presentation - May 2023
18/05/23		721.66KB	Share
TRI Change in Venue and Time for Extraordinary General Meeting
01/05/23		108.42KB	Share
TRI March 2023 Quarterly Activities Report and Appendix 4C
27/04/23	PRICE SENSITIVE	399.18KB	Share
TRI Letter to Shareholders & Notice of EGM & Proxy Form
21/04/23		634.19KB	Share
TRI MEB Executes Bridging Loans with Directors
21/04/23	PRICE SENSITIVE	143.06KB	Share
TRI Initial Director's Interest Notice - Thomas Young
17/04/23		150.24KB	Share
TRI Share Purchase Plan Supplementary Prospectus
14/04/23	PRICE SENSITIVE	1.6MB	Share
TRI Final Director's Interest Notice
12/04/23		235.53KB	Share
TRI Board & Managment Changes & Change of Offices
12/04/23		230KB	Share
TRI Update on Share Purchase Plan Timetable
06/04/23		238.93KB	Share
TRI Appendix 3Z
16/03/23		226.53KB	Share
TRI Resignation of Non-Executive Director
16/03/23		182.05KB	Share
TRI Share Purchase Plan Prospectus
02/03/23	PRICE SENSITIVE	575.38KB	Share
TRI Medibio Lodges Breakthrough Device Designation with FDA
27/02/23		238.29KB	Share
TRI Update to Share Purchase Plan Timetable
24/02/23		221.92KB	Share
TRI Half Yearly Report and Accounts
24/02/23	PRICE SENSITIVE	701.09KB	Share
TRI Change in substantial holding
23/02/23		176.43KB	Share
TRI 708A Cleansing Notice
23/02/23		173.49KB	Share
TRI Application for quotation of securities - MEB
21/02/23		24.85KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 2.9¢		Change -0.003(9.38%)		Mkt cap ! $9.816M

Open	High	Low	Value	Volume
3.2¢	3.2¢	2.9¢	$100.0K	3.241M

Buyers (Bids)

No.	Vol.	Price($)
3	610855	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	104232	2

View Market Depth

No.	Vol.	Price($)
3	610855	0.029
6	1671487	0.028
7	1821722	0.027
12	2513819	0.026
19	6230039	0.025

Price($)	Vol.	No.
0.030	104232	2
0.033	133332	2
0.036	232405	1
0.037	192542	2
0.038	238000	3

Last trade - 16.10pm 09/05/2024 (20 minute delay)


Last 2.9¢		Change -0.003 ( 9.38 %)
Open	High	Low	Volume
3.0¢	3.3¢	2.9¢	401506
Last updated 15.56pm 09/05/2024 ?

TRI (ASX) Chart

TRIVARX LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available